GOG-3110/ENGOT-EN28 Bluestar-Endometrial01 Clinical Trial Update

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4 Selected Advanced/Metastatic Endometrial Cancer Who Progressed On or After Platinum Based Chemotherapy and Anti-PD-1/Anti-PD-L1 Therapy

This is a Phase III, 2-arm, randomized, open label, multicenter, global study assessing the efficacy and safety of puxitatug samrotecan compared to physician's choice of chemotherapy (doxorubicin or paclitaxel) in participants with B7-H4 selected advanced/metastatic EC that progressed following platinum based chemotherapy and anti-PD-1/anti-PD-L1 therapy.

★ Support this podcast ★

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(22)

GOG-3133 FRAmework-01 Clinical Trial Update

We are pleased to share that the video recording for the GOG-3133 FRAmework-01 clinical trial is now available for on‑demand viewing.In this video, Dr. Roisin O'Cearbhaill and Dr. Bhavana Pothuri prov...

25 Sep 12min

GOG-3103/ ENGOT-ov84/ TroFuse-022 Clinical Trial Update

16 Sep 11min

GOG-3073/ ENGOT-ov72/ APGOT-Ov10/ LACOG-0223/ ROSELLA FDA APPROVAL PODCAST

10 Juli 9min

InnovaTV 205 GOG-3024/ENGOT-cx8 Publication Podcast

26 Juni 11min

Uterine Cancer Awareness Month 2026 Podcast

26 Juni 7min

Accrual Culture: Top Points for Site Selection - Timelines

The GOG Foundation, Inc. would like to thank our commercial supporters for their support of the GOG GYN-LIVE Podcast:Corcept Therapeutics, GSK, Pfizer Oncology, Eli Lilly, Genmab, and Verastem ★ Su...

2 Apr 20min